About Virarazer Tablets Aprazer
Specification :-
Brand Name : Virarazer
Content : Tenofovir Disoproxil Fumarate Emtricitabine & Efavirenz
Form : Tablets
Strength : 300mg/200mg/600mg
Packing : Pack Of 30 Tablets
Manufactured By-: Aprazer
Note :- Virarazer Is A Prescription Drug And Should Be Used Under Proper Medical Guidance And Advice. Do Not Share The Medicine With Others, Since They May Be Suffering From A Problem That Is Not Effectively Treated By This Drug.
Effective HIV-1 ManagementVirarazer Tablets deliver a powerful combination of three well-established antiretroviral agents, targeting multiple stages of the HIV lifecycle. This supports viral suppression and improves immune function, essential for long-term health in HIV-1 positive adults. Its all-in-one daily dosing simplifies adherence for individuals undergoing ART.
Safe and Convenient DosageEvery box contains 30 capsule-shaped, white tablets, suitable for a full months supply. The oral tablets are designed for adult use under strict medical supervision, with dosage generally taken once daily as recommended by your physician. Always follow prescribed dosage and consult your healthcare provider for pediatric use or dosage adjustments.
International Quality AssuranceDistributed internationally from India, Virarazer maintains stringent quality standards in manufacturing, packaging, and export. With a 24-month shelf life and robust protective packaging, these tablets remain potent and safe when stored below 30C and kept away from moisture.
FAQs of Virarazer Tablets Aprazer:
Q: How should Virarazer Tablets be administered for best results?
A: Virarazer Tablets should be taken orally once daily, exactly as prescribed by your healthcare professional. Swallow the capsule-shaped tablet whole, with or without food, and avoid altering the dosage without medical advice.
Q: What are the main benefits of using Virarazer Tablets for HIV-1 treatment?
A: Virarazer combines Tenofovir Disoproxil Fumarate, Emtricitabine, and Efavirenz, providing a comprehensive antiretroviral approach. This combination improves viral suppression and immune health, supports long-term management of HIV-1, and reduces the risk of disease progression.
Q: When is Virarazer contraindicated and who should avoid it?
A: Virarazer should not be used during pregnancy or by individuals with severe liver or kidney impairment. Always consult your doctor before starting therapy, and inform them of all health conditions and concurrent medications.
Q: What precautions should be taken while using Virarazer Tablets?
A: Use Virarazer only under strict medical supervision. Possible side effects include rash, dizziness, or nausea. Notify your healthcare provider if you experience severe or persistent symptoms. Routine monitoring may be needed during treatment.
Q: Where should Virarazer Tablets be stored to maintain their efficacy?
A: Keep Virarazer Tablets in their original packaging, stored below 30C and away from moisture. Avoid exposure to direct sunlight or heat sources to preserve potency throughout the shelf life.
Q: What is the process for starting Virarazer treatment?
A: Initiation of Virarazer therapy should be done under the guidance of an experienced healthcare professional following a confirmed HIV-1 diagnosis. The doctor will determine the appropriate dosage and monitor response throughout the course of treatment.